Opinion|Videos|January 2, 2025
Symptoms Associated With Polycythemia Vera
Author(s)Julie Huynh-Lu, P.A.
A panelist discusses how polycythemia vera (PV) symptoms can vary significantly among patients, but commonly include headaches, dizziness, itching (especially after warm baths), fatigue and visual disturbances, with some patients experiencing more severe manifestations like blood clots while others may be relatively asymptomatic.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Can you tell us what symptoms a patient might experience with PV?
- What are the most frequent symptoms seen in patients with PV?
- How much variability is there in symptoms from patient to patient?
Advertisement
Related to this article
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
A new trial will test whether a set course of Brukinsa plus sonrotoclax, which target two pathways that drive hairy cell leukemia, can offer an alternative to chemotherapy.
In the phase 2 MASTERPLAN trial, adding SBRT to chemotherapy lowered the rate of cancer returning near the pancreas from 52.0% to 20.2% at one year.
Dr. Saum Ghodoussipour of Rutgers Cancer Institute answers top searched bladder cancer questions, from treatment and surgery side effects to sex and work.
From a new chemotherapy combination to the first RAS-targeted pill, here's what five years of pancreatic cancer approvals mean for patients.
Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient cancer.
Medicare will move ostomy supplies to six national contracts in 2028. Survivors and clinicians say a poor fit can lead to leaks, infection and hospital stays.
An experimental treatment has kept one patient with heavily pretreated hairy cell leukemia free of detectable disease for more than two years, raising questions about whether CAR T-cell therapy could offer a path toward a cure.
Advertisement
Advertisement
Trending on CURE
1
Precision Radiation Cuts 1-Year Pancreatic Cancer Recurrence to 20.2%
2
3 Prostate Cancer Results From ESMO 2026 Patients Should Know
3
Urologic Oncologist Answers Top Searched Questions in Bladder Cancer
4
Medicare to Cut Ostomy Suppliers to 6 Contracts: What Patients Need to Know
5